Your browser doesn't support javascript.
loading
Patient and Provider Factors Associated With Initiating Sodium-Glucose Cotransporter-2 Inhibitors (SGTL2is) Following FDA Approval for Heart Failure With Preserved and Mildly Reduced Ejection Fraction.
Martyn, Trejeeve; Saef, Joshua; Bansal, Agam; Martinez, Kathryn A; Block-Beach, Hunter; Hohman, Jessica; Kapadia, Samir R; Desai, Milind Y; Estep, Jerry D; Albert, Nancy M; Starling, Randall C; Tang, W H Wilson.
Afiliación
  • Martyn T; Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland, Ohio; Kaufman Center for Heart Failure Treatment and Recovery, Cleveland Clinic, Cleveland, Ohio. Electronic address: martynm2@ccf.org.
  • Saef J; Joe DiMaggio Children's Hospital Heart Institute and Memorial Cardiac and Vascular Institute, Hollywood, Florida.
  • Bansal A; Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland, Ohio.
  • Martinez KA; Primary Care Institute, Cleveland Clinic, Cleveland, Ohio; Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio.
  • Block-Beach H; Primary Care Institute, Cleveland Clinic, Cleveland, Ohio.
  • Hohman J; Primary Care Institute, Cleveland Clinic, Cleveland, Ohio; Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio.
  • Kapadia SR; Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland, Ohio.
  • Desai MY; Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland, Ohio.
  • Estep JD; Cleveland Clinic Florida, Weston, Florida.
  • Albert NM; Kaufman Center for Heart Failure Treatment and Recovery, Cleveland Clinic, Cleveland, Ohio; Nursing Institute, Cleveland Clinic, Cleveland, Ohio.
  • Starling RC; Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland, Ohio; Kaufman Center for Heart Failure Treatment and Recovery, Cleveland Clinic, Cleveland, Ohio.
  • Tang WHW; Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland, Ohio; Kaufman Center for Heart Failure Treatment and Recovery, Cleveland Clinic, Cleveland, Ohio.
J Card Fail ; 30(4): 630-632, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38367905
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Disfunción Ventricular Izquierda / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Límite: Humans Idioma: En Revista: J Card Fail Asunto de la revista: CARDIOLOGIA Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Disfunción Ventricular Izquierda / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Límite: Humans Idioma: En Revista: J Card Fail Asunto de la revista: CARDIOLOGIA Año: 2024 Tipo del documento: Article